AASLD funds over $2.2 million in research, career development awards
The American Association for the Study of Liver Diseases Foundation announced its combined investment of over $2.2 million in research and career development awards, abstract awards, and its Emerging Liver Scholars program.
According to the release, the 2020 award recipients demonstrated aptitude and interest in liver disease research and treatment and will advance the mission of the AASLD Foundation and hepatology as a medical specialty.
“Liver disease continues to be a critical healthcare issue in the United States and globally,” Bruce A. Luxon, MD, PhD, FAASLD, chair, AASLD Foundation Board of Trustees told Healio Gastroenterology. “This funding translates into vital research that drives favorable patient outcomes, bringing us closer to our vision of preventing and curing liver disease. It enables us to continue providing critical funding for liver research, securing education and training for those caring for people with liver disease, encouraging young investigators who are new to the field, and increasing access to trained providers. Despite this year’s significantly challenging socioeconomic climate and its far-reaching impact on global communities, AASLD Foundation continues to provide more funding of hepatology research and training than any other private organization in the United States, and we have the generosity of our loyal supporters and community to thank for that.”
The funding will enable 24 researchers and clinicians to perform liver disease research and seek hepatology training through research and career development awards. investigators received abstract awards recognize their scientific excellence and promoted professional development through an opportunity to present at AASLD’s The Liver Meeting. Twenty residents have the opportunity through the Emerging Liver Scholars program to network, to learn and have a mentorship in the hepatology field.
The AASLD Foundation received funding from other donors included funding for research in autoimmune hepatitis and primary sclerosing cholangitistwo additional AASLD Foundation pilot research awards in AIH and funding from PSC Partners Seeking a Cure, which made it possible for AASLD to fund a second PSC pilot award.